Upgrade to SI Premium - Free Trial

Perrigo (PRGO) Announces Receipt of Final FDA Approval for Generic KlorCon Tabs

November 10, 2015 8:25 AM
Perrigo (NYSE: PRGO) announced it has received an AB therapeutic equivalent rating and final U.S. Food and Drug Administration ("FDA") ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles